Eli Lilly and InSilico Partner for AI-Powered Drug Discovery

Pharmaceutical giant Eli Lilly has entered into a strategic agreement with InSilico, a company specializing in artificial intelligence, to collaborate on AI-driven drug discovery initiatives, aiming to accelerate the development of new medicines.